JoVE Journal
Medicine
Medicine
Ce contenu est en libre accès.
Chapitres
résumé
Tumor-initiating cells (TICs) may represent a viable therapeutic target for the treatment of ovarian cancer, a highly recurrent and fatal disease. We present a protocol for culture conditions that enrich for this highly tumorigenic population of cells.